Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table

被引：86

作者：

Grosset, K

Needleman, F

Macphee, G

Grosset, D ^{[1
]}

机构：

[1] So Gen Hosp, Dept Neurol, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland

[2] So Gen Hosp, Dept Clin Pharm, Glasgow, Lanark, Scotland

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 11期

关键词：

Parkinson's disease; dopamine agonists; ergot;

D O I：

10.1002/mds.20210

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Of 99 patients on ergot-derived dopamine agonists informed about possible long-term side effects, switching to a nonergot was undertaken in 88 (89%). There were adverse events in 26%. After 11 months, 82% were on their switch agonist and 93% were on any agonist. Switching dopamine agonists is feasible in this population. (C) 2004 Movement Disorder Society.

引用

页码：1370 / 1374

页数：5

共 24 条

[1] Benard A, 1996, REV MAL RESPIR, V13, P227
[2] An overnight switch to ropinirole therapy in patients with Parkinson's disease
Canesi, M
Antonini, A
Mariani, CB
Tesei, S
Zecchinelli, AL
Barichella, M
Pezzoli, G
[J]. JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (9-10) : 925 - 929
[3] *EC PHARM COMM, 1998, GUID REL LAB PACK LE
[4] Cabergoline in Parkinson's disease complicated by motor fluctuations
Geminiani, G
Fetoni, V
Genitrini, S
Giovannini, P
Tamma, F
Caraceni, T
[J]. MOVEMENT DISORDERS, 1996, 11 (05) : 495 - 500
[5] Giménez-Roldán S, 2001, CLIN NEUROPHARMACOL, V24, P346
[6] Switching dopamine agonists in advanced Parkinson's disease - Is rapid titration preferable to slow?
Goetz, CG
Blasucci, L
Stebbins, GT
[J]. NEUROLOGY, 1999, 52 (06) : 1227 - 1229
[7] AGONIST SUBSTITUTION IN ADVANCED PARKINSONS-DISEASE
GOETZ, CG
SHANNON, KM
TANNER, CM
CARROLL, VS
KLAWANS, HL
[J]. NEUROLOGY, 1989, 39 (08) : 1121 - 1122
[8] Switching from pergolide to pramipexole in patients with Parkinson's disease
Hanna, PA
Ratkos, L
Ondo, WG
Jankovic, J
[J]. JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (01) : 63 - 70
[9] Ropinirole and pramipexole, the new agonists
Hobson, DE
Pourcher, E
Martin, WRW
[J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1999, 26 : S27 - S33
[10] Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Holloway, R
Shoulson, I
Kieburtz, K
McDermott, M
Tariot, P
Kamp, C
Day, D
Shinaman, A
Fahn, S
Lang, A
Marek, K
Seibyl, J
Weiner, W
Welsh, M
Pahwa, R
Coe, S
Barclay, L
Sutherland, L
Hildebrand, K
Hubble, J
Weeks, C
LeWitt, P
Miyasaki, J
Duff, J
Sime, E
Suchowersky, O
Stacy, M
Kurth, M
Brewer, M
Harrigan, M
Russell, DS
Fussell, B
Ford, B
Dillon, S
Hammerstad, J
Stone, C
Riley, D
Rainey, P
Standaert, D
Tennis, M
Wooten, F
Rost-Ruffner, E
Factor, S
Brown, D
Jankovic, J
Atassi, F
Kurlan, R
Gardiner, I
Panisset, M
Amyot, D
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15): : 1931 - 1938

← 1 2 3 →